Clinical Trial Update: Enamel Matrix Proteins in the Treatment of Intrabony Defects in Patients With Aggressive and Chronic Periodontitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating enamel matrix proteins for treating intrabony defects in patients with aggressive periodontitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aggressive Periodontitis

Drugs mentioned

• Enamel matrix proteins

Snippet

Sponsor: University of Campinas, Brazil | Conditions: Aggressive Periodontitis | Phase 4 | Status: COMPLETED